Arkadios Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
2,040
+1,631
| +399% | +$856K | 0.03% | 544 |
|
|
2025
Q1 | $259K | Buy |
+409
| New | +$259K | 0.01% | 950 |
|
|
2024
Q3 | – | Sell |
-202
| Closed | -$212K | – | 954 |
|
|
2024
Q2 | $212K | Buy |
+202
| New | +$212K | 0.01% | 745 |
|
|
2021
Q4 | – | Sell |
-56
| Closed | -$33K | – | 1492 |
|
|
2021
Q3 | $33K | Sell |
56
-1
| -2% | -$589 | ﹤0.01% | 1035 |
|
|
2021
Q2 | $31K | Buy |
57
+28
| +97% | +$15.2K | ﹤0.01% | 1115 |
|
|
2021
Q1 | $13K | Buy |
29
+24
| +480% | +$10.8K | ﹤0.01% | 1109 |
|
|
2020
Q4 | $2K | Sell |
5
-11
| -69% | -$4.4K | ﹤0.01% | 1271 |
|
|
2020
Q3 | $9.6K | Hold |
16
| – | – | ﹤0.01% | 755 |
|
|
2020
Q2 | $10.3K | Hold |
16
| – | – | 0.01% | 678 |
|
|
2020
Q1 | $7.81K | Buy |
+16
| New | +$7.81K | 0.01% | 687 |
|